← ANI PHARMACEUTICALS INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $27.4m | $31.1m | $43.0m | $62.3m | $7.9m | $100.3m | $48.2m | $221.1m | $144.9m | $285.6m | |
| Inventory, Net | $26.2m | $37.7m | $40.5m | $48.2m | $60.8m | $81.7m | $105.4m | $111.2m | $136.8m | $143.1m | |
| Assets, Current | $103.0m | $131.6m | $152.9m | $187.7m | $170.3m | $321.8m | $344.3m | $519.8m | $527.7m | $753.1m | |
| Property, Plant and Equipment, Net | $11.0m | $20.4m | $38.1m | $40.6m | $41.3m | $52.7m | $43.2m | $44.6m | $56.9m | $62.5m | |
| Goodwill | $1.8m | $1.8m | $3.6m | $3.6m | $3.6m | $27.9m | $28.2m | $28.2m | $60.0m | $62.5m | |
| Intangible Assets, Net (Excluding Goodwill) | $175.8m | $229.8m | $201.6m | $180.4m | $188.5m | $294.1m | $251.6m | $209.0m | $541.8m | $479.5m | |
| Other Assets, Noncurrent | — | $829k | $1.5m | $1.2m | $802k | $2.2m | $11.4m | $12.1m | $12.2m | $13.7m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $45.9m | $58.8m | $64.8m | $72.1m | $95.8m | $128.5m | $165.4m | $162.1m | $221.7m | $281.1m | |
| Accrued Liabilities, Current | $927k | $1.6m | $1.7m | $2.4m | $2.5m | $7.6m | $5.4m | $5.6m | $13.7m | $16.8m | |
| Assets | $322.9m | $412.1m | $430.6m | $456.8m | $461.2m | $771.6m | $760.1m | $904.4m | $1.3b | $1.4b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $197k | $129k | $387k | $684k | $1.6m | $1.8m | $1.9m | |
| Accounts Payable, Current | $3.4m | $3.6m | $8.9m | $14.6m | $11.3m | $23.0m | $29.3m | $36.7m | $45.7m | $62.6m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $292k | $172k | $995k | $1.4m | $4.1m | $4.4m | $9.2m | |
| Deferred Revenue, Current | — | — | $711k | $451k | — | — | — | — | — | — | |
| Long-term Debt, Current Maturities | — | $3.4m | $3.3m | $9.9m | $13.2m | $850k | $850k | $850k | $9.2m | $17.3m | |
| Long-term Debt, Excluding Current Maturities | — | $69.9m | $67.3m | $175.8m | $172.4m | $286.5m | $285.7m | $284.8m | $309.1m | $291.8m | |
| Liabilities, Current | $31.9m | $39.2m | $165.5m | $61.7m | $78.6m | $87.5m | $99.4m | $145.5m | $193.7m | $278.1m | |
| Other Liabilities, Noncurrent | — | — | $496k | $6.5m | $14.5m | $7.8m | $1.4m | $4.8m | $5.8m | $12.2m | |
| Liabilities | $153.2m | $237.4m | $233.3m | $244.0m | $265.5m | $412.9m | $421.5m | $446.8m | $855.2m | $899.7m | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 | $0 | $24.9m | $24.9m | $0 | $0 | $0 | |
| Common Stock, Value, Issued | $1k | $1k | $1k | $1k | $1k | $1k | $1k | $2k | $2k | $3k | |
| Additional Paid in Capital | $172.6m | $179.0m | $186.8m | $200.8m | $214.4m | $387.8m | $403.9m | $514.1m | $519.7m | $596.0m | |
| Retained Earnings (Accumulated Deficit) | ($2.9m) | ($4.0m) | $11.5m | $17.6m | ($5.0m) | ($47.8m) | ($97.3m) | ($80.1m) | ($100.3m) | ($23.1m) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | — | $0 | ($379k) | ($4.9m) | ($11.4m) | ($3.1m) | $12.2m | $8.9m | $5.3m | $1.0m | |
| Stockholders' Equity Attributable to Parent | $169.6m | $174.8m | $197.3m | $212.8m | $195.7m | $333.9m | $313.7m | $432.7m | $403.7m | $540.7m | |
| Liabilities and Equity | $322.9m | $412.1m | $430.6m | $456.8m | $461.2m | $771.6m | $760.1m | $904.4m | $1.3b | $1.4b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.